Benitec Limited (ASX:BLT)
Melbourne, May 6, 2009 AEST (ABN Newswire) - Leading developer of RNA interference (RNAi)-based therapeutics Benitec Limited (ASX:BLT)(PINK:BNIKF) announced today that Dr John Zaia had presented an update on City of Hope's HIV human stem cell study at an international conference in San Diego, USA.
Findings from the trial were presented at the International Society of Cell Therapy conference held in San Diego May 3-6 2009 by John A. Zaia M.D. the Aaron D. and Edith Miller Endowed Chair for Gene Therapy and chair of virology, Beckman Research Institute of City of Hope. City of Hope is a biomedical research and treatment facility located northeast of Los Angeles.
The presentation was entitled "Current status of Gene Therapy for HIV/AIDS" and was an update and confirmation of the previously presented encouraging results.
"These study results show that we can deliver gene modified cells which have the potential to limit the HIV infection. If we can continue to develop this approach and successfully apply it to other AIDS patients, then genetic therapy for HIV could become a reality", said Sue MacLeman, CEO Benitec Limited.
Contact
BENITEC LTD
Sue MacLeman
Chief Executive Officer
Tel: +61-437-211-200
| ||
|
